VALPOSAFE 300CR
COMPOSITION - Sodium Valproate 200 mg + Valproic Acid 87 mg (Controlled Release) Tablets
DESCRIPTION - VALPOSAFE 300 CR is a controlled-release anticonvulsant formulation. Sodium valproate and valproic acid increase gamma-aminobutyric acid (GABA) levels in the brain, enhancing inhibitory neurotransmission and stabilizing neuronal activity. This reduces abnormal electrical discharges responsible for seizures. The controlled-release formulation provides sustained plasma levels for improved seizure control and better patient compliance.
Uses
- Epilepsy
- Generalized seizures
- Partial seizures
- Neurological seizure disorders
- Bipolar disorder (as mood stabilizer)
Side Effects
- Nausea
- Weight gain
- Tremors
- Drowsiness
- Hair loss (temporary)
Precautions / Other Important Details
- Monitor liver function during therapy
- Use cautiously in patients with liver disease
- Avoid abrupt discontinuation
- Not recommended during pregnancy (risk of fetal harm)
- Regular monitoring of blood levels may be required
